Long-term trends in the incidence of and survival with heart failure.

By Daniel Levy, S. Kenchaiah, Martin G. Larson, Emelia J. Benjamin, Michelle J. Kupka, K. Ho, Joanne M. Murabito, Ramachandran S. Vasan. New England Journal of Medicine, 2002

2,222 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Complementary and alternative medicine

View Paper: https://www.semanticscholar.org/paper/a98903518bdfcc651d5f4202526193110186cc47

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. T. Horwich
3. Victor M. Montori
4. J. Januzzi
5. J. Heineke
6. J. Molkentin
7. C. Yancy
8. M. Drazner

Citations in the corpus

• Epidemiology of Heart Failure (2013, neutral): “In the Framingham Heart Study(70) and the Olmsted County Study(72) which include outpatient HF, the incidence of HF failure remained stable over time(72) or even declined in women.(70) It should be noted that, although the interpretation”
• Dilated Cardiomyopathy (2007, neutral): “Despite recent advances in medical treatment, LV dysfunction associated with signs of congestive heart failure (HF) is characterized by significant mortality [16].”
• The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004, result): “These data are comparable to survival curves published by Levy et al. in 2002 52 .”
• Regulation of cardiac hypertrophy by intracellular signalling pathways (2006, background): “Wu, X. et al. Local InsP(3)-dependent perinuclear Ca signaling in cardiac myocyte excitation-transcription coupling.”
• Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. (2004, methodology): “Congestive heart failure (CHF) remains common in western communities and contributes significantly to the burden of morbidity and mortality ( 1 ).”
• Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. (2016, background): “ter than men and HF in women frequently occurs in older age and with less ischaemic aetiology than in men.(79,80) Few studies determined the true incidence of HF with preserved ejection fraction”